Trends in Red Blood Cell Transfusions Within the Biologics Effectiveness and Safety (BEST) Initiative Network, 2012-2018

被引:0
|
作者
Obidi, Joyce [1 ]
Villa, Carlos Hipolito [1 ]
Storch, Emily [1 ]
Whitaker, Barbee I. [1 ]
Chada, Kinnera [1 ]
Williams, Alan [1 ]
Fowler, Stephanie [2 ]
Schilling, Lisa [3 ]
Kahn, Michael G. [3 ]
Edlavitch, Stanley A. [4 ]
Draper, Nicole [5 ]
Purkayastha, Saptarshi [6 ]
Hayden, Ross [6 ]
Biondich, Paul [6 ]
Falconer, Thomas [7 ]
Natarajan, Karthik [7 ]
Reich, Christian
Selvam, Nandini [2 ]
Shoaibi, Azadeh [1 ]
机构
[1] US FDA, CBER, Rockville, MD 20857 USA
[2] IQVIA Govt Solut, Fairfax, VA USA
[3] Univ Colorado, Anschutz Med Campus, Boulder, CO 80309 USA
[4] UMKC, Sch Med, Kansas City, MO USA
[5] Univ Colorado, Boulder, CO 80309 USA
[6] Regenstrief Inst Inc, Indianapolis, IN USA
[7] Columbia Univ, New York, NY 10027 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P-TS-44
引用
收藏
页码:205A / 206A
页数:2
相关论文
共 6 条
  • [1] Patterns of platelet use evaluated in EHR networks of the Biologics Effectiveness and Safety Initiative, 2012-2018
    Villa, Carlos H.
    Biondich, Paul
    Draper, Nicole L.
    Dores, Graca M.
    Storch, Emily
    Chada, Kinnera
    Wong, Hui-Lee
    Whitaker, Barbee
    Obidi, Joyce
    Vossoughi, Sarah
    Soares, Andrey
    Schilling, Lisa M.
    Natarajan, Karthik
    Goodman, Michael
    Purkayastha, Saptarshi
    Zucker, Rachel
    Falconer, Thomas
    Williams, Nerissa
    Reich, Christian
    Anderson, Steven
    Shoaibi, Azadeh
    TRANSFUSION, 2025, 65 (02) : 267 - 276
  • [2] Patterns of red blood cell utilization: Harnessing electronic health records data from the Information Standard for Blood and Transplant (ISBT) 128 system within the Biologics Effectiveness and Safety (BEST) initiative
    Obidi, Joyce
    Sridhar, Gayathri
    Dores, Graca M.
    Whitaker, Barbee
    Villa, Carlos H.
    Storch, Emily
    Chada, Kinnera
    Schilling, Lisa M.
    Natarajan, Karthik
    Biondich, Paul
    Soares, Andrey
    Spotnitz, Matthew
    Falconer, Thomas
    Purkayastha, Saptarshi
    Draper, Nicole L.
    Wong, Hui-Lee
    Stagg, Matthew
    Reich, Christian
    Anderson, Steven
    Shoaibi, Azadeh
    TRANSFUSION, 2024, 64 (06) : 998 - 1007
  • [3] Linkage of Mother and Infant Records using Commercial Claims Data within the Food and Drug Administration (FDA) Biologics Effectiveness and Safety (BEST) Initiative
    Zelaya, Carla E.
    Gruber, Joann F.
    Wan, Zhiruo
    Chillarige, Yoganand
    Cho, Sylvia
    Hu, Mao I.
    Lloyd, Patricia C.
    Avula, Ramya
    Lyu, Ruobing
    Bell, Elizabeth J.
    Djibo, Djeneba Audrey
    Clarke, Tainya C.
    Varvaro, Vincent
    Shah, Nimesh
    Shah, Purva
    Amend, Kandace L.
    Secora, Alex
    Selvam, Nandini
    McMahill-Walraven, Cheryl N.
    Seeger, John D.
    Deng, Jie
    Forshee, Richard A.
    Anderson, Steven A.
    Shoaibi, Azadeh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 464 - 464
  • [4] Characterization of US adults aged 18-64 years vaccinated against mpox within the food and drug administration biologics effectiveness and safety (BEST) initiative
    Gruber, Joann F.
    Matuska, Kathryn
    Wang, Jing
    Clarke, Tainya C.
    McMahill-Walraven, Cheryl N.
    Lloyd, Patricia C.
    Peetluk, Lauren S.
    Secora, Alex
    Hu, Mao
    Song, Jennifer
    Beachler, Daniel C.
    Chillarige, Yoganand
    Wong, Hui-Lee
    Tarazi, Wafa
    Djibo, Djeneba Audrey
    Forshee, Richard A.
    Anderson, Steven A.
    Shoaibi, Azadeh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 149 - 150
  • [5] Clinical Effectiveness and Safety of Momelotinib Compared with Continued Ruxolitinib or Best Available Therapy in Patients with Myelofibrosis Who Required Red Blood Cell Transfusions: Subgroup Analysis of the Phase 3 SIMPLIFY-2 Study
    Harrison, Claire
    Scheid, Christoph
    Vannucchi, Alessandro M.
    Recher, Christian
    Passamonti, Francesco
    Gerds, Aaron T.
    Hernandez-Boluda, Juan Carlos
    Yacoub, Abdulraheem
    Sirhan, Shireen
    Kawashima, Jun
    Patel, Bharat
    Strouse, Bryan
    Platzbecker, Uwe
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 118 - 118
  • [6] Combining COVID-19 vaccine data from claims with data from immunization information systems (IIS) to address exposure misclassification: An approach within the FDA biologics effectiveness and safety (BEST) initiative
    Bell, Elizabeth
    Zhou, Cindy
    Schneider, Karen L.
    Lloyd, Patricia
    Clarke, Tainya
    Yang, Grace
    Wilkinson, Michael
    Amend, Kandace
    Myers, Emily
    Anderson, Steven
    Shoaibi, Azadeh
    Seeger, John
    Wong, Hui-Lee
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 604 - 605